We have expressed in the yeast Saccharomyces cerevisiae a full-length poliovirus cDNA clone under the control of the GALIO promoter to better characterize the effect of poliovirus on host cell metabolism. We find that yeast cells are unable to translate poliovirus RNA in vivo and that this inhibition is mediated through the 5' untranslated region of the viral RNA. The in vivo inhibition of translation of poliovirus RNA and P2CAT RNA (which contains the 5' untranslated region fused upstream of the bacterial chloramphenicol transferase gene) can be mimicked in vitro in yeast translation lysates. In fact, a trans-acting inhibitor present in yeast lysates can inhibit translation of either poliovirus or P2CAT RNA in HeLa cell translation lysates. In contrast, when the inhibitor is added to translations programmed with chloramphenicol acetyltransferase RNA, yeast prepro-a-factor RNA, or an RNA containing the internal ribosome entry site of encephalomyocarditis virus, no inhibition is seen. The inhibitory activity has been partially purified by DEAE-Sephacel chromatography. The partially purified inhibitor is heat stable, escapes phenol extraction, is resistant to proteinase K and DNase I treatment, and is sensitive to RNase A digestion, suggesting that the inhibitor is an RNA. In an in vitro translation assay, the inhibitory activity can be overcome by increasing the concentration of HeLa cell lysate but not P2CAT RNA, suggesting that the inhibitor interacts (directly or indirectly) with one or more components of the HeLa cell translational machinery rather than with the viral RNA.
Poliovirus is a member of the Picornaviridae family. It contains a single-stranded, positive-polarity RNA which is 7.4 kb in length (19, 31) . The RNA is not capped, but instead has a small virus-encoded protein, VPg, linked to its 5' end. VPg is rapidly removed upon infection or introduction of the RNA into cell-free translation lysates, leaving pUp at the 5' end of the RNA. Type 1 poliovirus contains a long untranslated region (UTR; 742 nucleotides) with eight short open reading frames (ORFs; some overlapping) upstream of the initiator methionine codon. Disruption of these ORFs by linker insertion or by a point mutation of each AUG shows that they do not play a role in viral replication (26, 37) . Recent evidence indicates that ribosomes do not scan poliovirus RNA from the 5' end, as is the case for most eukaryotic mRNAs (21) . Instead, sequences between nucleotides 320 and 631 appear to mediate cap-independent, internal initiation of translation (5, 27, 29, 38) . The sequences responsible for internal initiation are referred to as the internal ribosome entry site (IRES) (15, 16; reviewed in 14) . A similar internal entry of ribosomes also has been seen with two other picornaviruses, encephalomyocarditis virus (ECMV) (16) and foot-and-mouth disease virus (4) . Recently, the cellular mRNA encoding the immunoglobulin heavy-chain-binding protein was also shown to be capable of internal initiation (22) .
Poliovirus RNA is translated as a polyprotein which is self-cleaved by virus-encoded proteases, releasing structural and nonstructural proteins. The presence of viral proteins leads to a rapid shutoff of host cell transcription and translation caused by modification (e.g., proteolysis or dephos-* Corresponding author. phorylation) of specific cellular factors (9, 10, 18, 20, 35) . Complete characterization of these altered factors has been hampered in part by the logistical problems of obtaining a large amount of starting material for cellular protein purification and the inability to genetically manipulate HeLa cells. However, these limitations can be overcome by studying gene regulation in yeast cells. The mechanisms of transcription and translation in yeast cells are functionally similar to those of the mammalian system. In fact, yeast transcription factor IID (TFIID, the TATA-binding factor) can substitute for human TFIID in reconstituted transcription assays (7, 8) , and mammalian translation initiation factor eIF-4E can substitute for yeast eIF-4E in vivo (2) . Thus, the presence of poliovirus proteins in yeast cells would be expected to result in effects similar to those seen in infected HeLa cells.
In this study we have expressed a poliovirus cDNA clone in Saccharomyces cerevisiae with the hope of better characterizing the effect of poliovirus on cellular processes. Interestingly, we find that yeast cells are unable to translate poliovirus RNA in vivo and that this effect is a consequence of the 5' UTR of the viral RNA. The inability of yeast cells to translate RNAs containing the 5' UTR can also be demonstrated in vitro with cell-free translation assays. This effect appears to be due to a trans-acting factor, since an activity present in yeast cell lysates inhibits the ability of HeLa cell extracts to translate these same RNAs. The activity binds strongly to DEAE-Sephacel, eluting at between 0.6 and 1.0 M potassium acetate. Initial characterization of the inhibitory activity suggests that it is an RNA rather than a protein and that it interacts (directly or indirectly) with a component of the HeLa cell translational machinery.
MATERIALS AND METHODS
Cells and viruses. HeLa cells were grown as Spinner cultures in minimal essential medium (GIBCO Laboratories) supplemented with 1 g of glucose per liter and 6% newborn calf serum. Poliovirus RNA (type 1 Mahoney) was prepared as described previously (36) . The S. cerevisiae strain used was YM259 (a his3A200 tyri ade2-101ch ura3-52 GAL SUC2), provided by M. Grunstein.
Plasmid construction. pUC19CAT was provided by R.
Gaynor. The HindIII-BamHI fragment containing the chloramphenicol acetyltransferase (CAT) gene was subcloned into pGEM3, creating pG3CAT. pP2CAT was created by digesting vector pP25' (provided by V. Racaniello [27] Partial purification and characterization of the inhibitor. Yeast cell lysates were made as described above, except that they were not treated with micrococcal nuclease. Lysates were batch loaded onto DEAE-Sephacel (Pharmacia) which had been equilibrated with lysis buffer (100 mM KOAc). Fractions were step eluted at 0.3, 0.6, and 1.0 M KOAc, dialyzed back to 100 mM KOAc, divided into aliquots, and frozen at -70°C. The 1.0 M DEAE fraction was heat treated for 10 min at 95°C and centrifuged in a Microfuge briefly to pellet debris, and the supernatant was divided into aliquots and frozen. Phenol extraction involved extraction with phenol-chloroform equilibrated with RNA buffer (0.5 M NaCl, 200 mM Tris [pH 7.5], 10 mM EDTA [4] ) and extraction with chloroform only. Approximately one-half of the aqueous volume was collected from each extraction to eliminate any possibility of disturbing the interface. (Fig. 1) . Yeast cells transformed with pBMCAT and pBMP2CAT were induced to express the CAT genes with galactose, and total RNA was extracted and subjected to Northern analysis. When hybridized to a 32P-labeled CAT antisense riboprobe, these blots showed the presence of intact RNAs of the appropriate sizes for CAT and P2CAT mRNAs (Fig. 3A, lanes 2 and 3) . RNA (Fig. 3B, lane  2) . Yeast cells transformed with pBMP2CAT did not make any CAT protein (Fig. 3B, lane 3) , despite the presence of CAT-specific RNA in yeast cells transformed with this construct (Fig. 3A, lane 3) . Longer exposures of the film also failed to detect CAT protein in yeast cells transformed with pBMP2CAT (data not shown). Thus, the RNA containing the 5' UTR was not translated in vivo. To investigate the mechanism of this translational inhibition, we used cell-free translation systems to translate CAT, P2CAT, and poliovirion RNAs.
RESULTS
Inhibition of translation in vitro: evidence for a translational inhibitor in yeast cells. HeLa and yeast cell lysates were used to translate CAT, P2CAT, and poliovirion RNAs in vitro. HeLa cell lysates translated poliovirus RNA (Fig. 4A, lanes  2 and 3) , CAT RNA (Fig. 4B, lane 1) , and P2CAT RNA (Fig.  4B, lane 4) quite efficiently. Consistent with the in vivo results (Fig. 2 and 3 ), yeast cell lysates were able to translate CAT RNA (Fig. 4B, lane 3) but not P2CAT RNA (Fig. 4B,  lane 6 ) or poliovirion RNA (Fig. 4A, lane 5) . Interestingly, the addition of a small amount of yeast cell lysate to the HeLa cell translation reactions prevented translation of RNAs containing the 5' UTR (Fig. 4A, lane 4, (Fig. 4B, lane 2) . The addition of lysis buffer did not affect translation of P2CAT RNA (Fig. 5 and 6 and data not shown), implying that the inhibition was not simply a consequence of buffer conditions. These results suggest that yeast cells contain a translational inhibitor whose effects are mediated through the UTR and which functions in trans.
It was possible that one of the short ORFs found in the poliovirus 5' UTR was translated in the presence of yeast cell lysates, resulting in a protein product which inhibited translation. To address this possibility, we preincubated yeast cell translation lysates for 10 min with either P2CAT RNA or an RNA encoding only the 5' UTR, added CAT RNA, and continued incubation for another 60 min. Under these conditions, CAT RNA was still translated with the same efficiency as when there was no RNA present during the preincubation step, indicating that the ORFs present in the poliovirus 5' UTR do not code for a translational repressor (data not shown). While it cannot be ruled out that a leader peptide which specifically inhibits internal initiation is translated, we feel that this possibility is unlikely since (i) it appears that these ORFs are not translated either in poliovirus-infected HeLa cells or in cell-free translation systems (26, 37) and (ii) the inhibitory activity has been partially purified and appears not to be a protein, but an RNA (see below).
Partial purification and initial characterization of the inhibitory activity. Yeast cell lysates were fractionated on a DEAE-Sephacel column to partially purify the inhibitory activity. Extracts were prepared by the same protocol as that used for translation extracts but were not treated with micrococcal nuclease. Extracts were loaded onto DEAE at 0.1 M KOAc and step eluted at 0.3, 0.6, and 1.0 M KOAc. The fractions were dialyzed back to 0.1 M salt and assayed for the ability to inhibit translation of P2CAT RNA by HeLa cell translation lysates. As a control for nonspecific effects, the fractions were also tested for their effect on the translation of CAT RNA by HeLa cell lysates. Both the flowthrough and the 0.3 M wash inhibited translation of P2CAT RNA slightly (Fig. 5, lanes 3 and 4) , but this effect was also seen with CAT RNA (lanes 9 and 10) and thus was probably nonspecific. The 0. To better characterize the inhibitory activity, we heat treated the 1.0 M column fraction to determine whether the activity was heat stable or labile. The partially purified inhibitor was heated at 95°C for 10 min and spun briefly in a Microfuge to pellet debris, and the supernatant was added to HeLa cell translation lysates containing P2CAT RNA. The inhibitor still retained its activity after this treatment ( ( Fig. 6B, lanes 1 to 3) . These data suggested that the inhibitor was either a very heat-stable protein or perhaps a nucleic acid or nucleoprotein.
Because the lysates had not been treated with micrococcal nuclease prior to fractionation, it was possible that the activity would be sensitive to this nuclease. However, treatment of the 1.0 M DEAE column fraction with micrococcal nuclease and inactivation of the nuclease with EGTA had no effect on the ability of the inhibitor to inhibit translation of P2CAT RNA by HeLa cell lysates (data not shown). The nuclease was active, however, since it was able to digest 10 ,ug of total yeast RNA under identical reaction conditions. Phenol-chloroform extraction was used to determine whether the inhibitory activity had a protein component. Lysis buffer which had been extracted with phenol-chloroform slightly inhibited translation of P2CAT RNA and served as a control for the toxicity of the extraction process (Fig. 6A, lane 5) . Extraction of the heat-treated inhibitor with phenol-chloroform did not remove the inhibitory activity (compare lanes 5 and 6). This observation allowed for digestion of the heat-treated inhibitor with RNase A and proteinase K, two enzymes which could not be adequately inhibited by chemical means but which could be removed by phenol extraction. Heat-treated inhibitor was incubated with 100 ,ug of RNase A or 10 ,ug of proteinase K per ml at 37°C for 15 min, phenol-chloroform extracted, and added back to HeLa cell translation lysates containing P2CAT RNA. Since any residual RNase A or proteinase K activity would have inhibited the translation reactions, buffer alone was also treated with these enzymes, extracted with phenol-chloroform, and added to the translation reaction mixtures. Buffer thus treated did not affect translation of P2CAT RNA, indicating that the enzymes were completely removed by phenol extraction (lanes 7 and 9) . Incubation of the heattreated fraction with proteinase K did not remove the inhibitor (lane 8), while RNase A treatment effectively removed all inhibitory activity, allowing translation of P2CAT RNA (lane 10). Thus, the inhibitor appears to be an RNA molecule. Precisely why it is resistant to micrococcal nuclease treatment is not known, but this resistance could be due to the presence of an extensive secondary structure.
The next experiments were aimed at determining whether the inhibitor mediated its effect directly through the poliovirus 5' UTR or through an interaction with a HeLa cell factor needed specifically for translation of P2CAT RNA. To differentiate between these two possibilities, we added an excess of either P2CAT RNA or HeLa cell lysate to the reaction mixtures to saturate the inhibitor and restore translation. Unfortunately, HeLa cell translation lysates were sensitive to high levels of protein and RNA, so that the addition of a very large excess of either was not possible. However, it appears that a small increase in the amount of HeLa cell lysate used for translation could overcome the inhibition seen with the heat-treated inhibitor, while an increase in the RNA amount could not. Translational inhibition (Fig. 7A, compare lanes 1 and 4) could be overcome by increasing the amount of HeLa cell lysate used in the translation reaction (lanes 5 and 6). The same titration of HeLa cell lysate in the absence of the inhibitor did not result in a significant change in the amount of CAT protein produced (lanes 1 to 3) . In a second experiment, the HeLa cell lysate concentration was kept constant while P2CAT RNA was titrated over a sixfold range (Fig. 7B) . In the absence of the inhibitor, the level of translation remained essentially constant with two-, four-, and sixfold increases in P2CAT RNA levels (compare lane 1 with lanes 2, 3, and 4 (6, 12) . The yeast inhibitor used in these experiments was purified in a slightly different manner from that used before, as described in the legend to Fig. 8 . The inhibitor still maintained its specificity for P2CAT RNA, as the addition of the inhibitor prevented translation of P2CAT RNA but not CAT RNA (Fig. 8 (1) . Perhaps in this strain the inhibitor is present in lower amounts or the putative target factor is present in higher amounts. We have been unable to detect any translation of P2CAT RNA in the two strains that we have used ( Fig. 2 and 3 and data not shown) .
Finally, what is the function of the inhibitor in yeast cells? Macejak and Sarnow have recently published a report showing that internal initiation can take place on the cellular mRNA encoding the immunoglobulin heavy-chain-binding protein (22) . The authors speculate that this mRNA may be translated by both cap-dependent and cap-independent mechanisms, possibly in a cell cycle-dependent manner (correlating with the phosphorylation state of eIF-4F) (22) . An intriguing possibility is that yeast cells contain genes which initiate translation internally and that the inhibitory RNA described here can be used to regulate the expression of these genes posttranscriptionally. Purifying and sequencing of the inhibitor and determining its mode of action will help us define any role it may have in translation in yeast cells.
